Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEXT-CAT: Edoxaban vs Apixaban in Cancer-Associated Thrombosis
NCT07852637Phase 4Not yet recruiting
- Sponsor
- Samsung Medical Center
- Start
- Nov 2026
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
A Phase 4 trial of edoxaban in venous thromboembolism (VTE), sponsored by Samsung Medical Center. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
edoxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT07852637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07852637.